Amber Chevalier
Amber Chevalier spoke at National Society of Genetic Counselors (NSGC) Annual Conference 2026 in November 2026 (speaker, “Demystifying MRD: The Genetic Counselor’s Role in ctDNA-Based Cancer Monitoring and Minimal Residual Disease Detection”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Amber. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Amber is a board certified genetic counselor with a background in clinical genetics, variant science, and medical affairs. She leads clinical development and research collaboration for NeoGenomics’ ctDNA profiling and MRD assays. Her team is responsible for internal subject matter support for liquid biopsy, solid tumor, and heme diagnostic assays.